Insiders · Profile

Garland J. Scott

Director at Enliven Therapeutics. Filing since 1 Oct 2026. CIK 0001533228

Company

Date

Role

Action

Shares

Amount

Of holding

ELVN Enliven Therapeutics, Inc.

1 Oct 2026

Director

Sold at will

13,000

$606.72K

100%

1 decision on file.